124 related articles for article (PubMed ID: 17045164)
1. Synthesis and evaluation of a bromine-76-labeled PPARgamma antagonist 2-bromo-5-nitro-N-phenylbenzamide.
Lee H; Finck BN; Jones LA; Welch MJ; Mach RH
Nucl Med Biol; 2006 Oct; 33(7):847-54. PubMed ID: 17045164
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands.
Rowland DJ; Tu Z; Xu J; Ponde D; Mach RH; Welch MJ
J Nucl Med; 2006 Jun; 47(6):1041-8. PubMed ID: 16741315
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-{gamma}.
Mathews WB; Foss CA; Stoermer D; Ravert HT; Dannals RF; Henke BR; Pomper MG
J Nucl Med; 2005 Oct; 46(10):1719-26. PubMed ID: 16204723
[TBL] [Abstract][Full Text] [Related]
4. The Peroxisome Proliferator-Activated Receptor (PPAR)-
Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 18F-labeled PPARγ antagonists.
Lee H; Chen DL; Rothfuss JM; Welch MJ; Gropler RJ; Mach RH
Nucl Med Biol; 2012 Jan; 39(1):77-87. PubMed ID: 21907585
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
Parent EE; Dence CS; Jenks C; Sharp TL; Welch MJ; Katzenellenbogen JA
J Med Chem; 2007 Mar; 50(5):1028-40. PubMed ID: 17328524
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
9. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Zhou D; Sharp TL; Fettig NM; Lee H; Lewis JS; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 2008 Aug; 35(6):655-63. PubMed ID: 18678350
[TBL] [Abstract][Full Text] [Related]
11. Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion.
Winberg KJ; Persson M; Malmström PU; Sjöberg S; Tolmachev V
Nucl Med Biol; 2004 May; 31(4):425-33. PubMed ID: 15093812
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
13. 4-
Garg PK; Nazih R; Wu Y; Singh R; Garg S
J Nucl Med; 2017 May; 58(5):827-832. PubMed ID: 27980051
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents.
Lee BC; Dence CS; Zhou H; Parent EE; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2009 Feb; 36(2):147-53. PubMed ID: 19217526
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
[TBL] [Abstract][Full Text] [Related]
17. Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability.
Kapetanovic IM; Lyubimov AV; Kabirova EV; Kabirov KK; Rasay L; Swezey R; Green C; Kopelovich L
Chem Biol Interact; 2012 Apr; 197(1):16-22. PubMed ID: 22450444
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
